Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5388) 5388
Newsletter (143) 143
Magazine Article (36) 36
Book Chapter (34) 34
Dissertation (6) 6
Newspaper Article (6) 6
Web Resource (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Publication (2) 2
Government Document (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3949) 3949
sulfasalazine - therapeutic use (2455) 2455
science & technology (2201) 2201
male (2128) 2128
life sciences & biomedicine (2098) 2098
female (2035) 2035
sulfasalazine (1914) 1914
adult (1620) 1620
middle aged (1307) 1307
biological and medical sciences (1147) 1147
sulfasalazine - adverse effects (1128) 1128
medical sciences (1116) 1116
arthritis, rheumatoid - drug therapy (908) 908
colitis, ulcerative - drug therapy (904) 904
pharmacology. drug treatments (756) 756
aged (753) 753
abridged index medicus (741) 741
rheumatology (685) 685
animals (650) 650
rheumatoid arthritis (625) 625
sulfasalazine - pharmacology (624) 624
drug therapy, combination (569) 569
antirheumatic agents - therapeutic use (564) 564
sulfasalazine - administration & dosage (564) 564
treatment outcome (527) 527
crohn disease - drug therapy (488) 488
anti-inflammatory agents, non-steroidal - therapeutic use (487) 487
adolescent (485) 485
methotrexate - therapeutic use (454) 454
methotrexate (417) 417
mesalamine (391) 391
ulcerative colitis (378) 378
gastroenterology & hepatology (360) 360
pharmacology & pharmacy (360) 360
time factors (313) 313
drug therapy (296) 296
rats (282) 282
bones, joints and connective tissue. antiinflammatory agents (279) 279
child (271) 271
inflammatory bowel disease (254) 254
research (250) 250
adrenal cortex hormones - therapeutic use (246) 246
care and treatment (234) 234
aminosalicylic acids - therapeutic use (232) 232
clinical trials as topic (232) 232
antirheumatic agents - adverse effects (228) 228
arthritis (226) 226
analysis (219) 219
double-blind method (216) 216
anti-inflammatory agents - therapeutic use (214) 214
immunosuppressive agents - therapeutic use (212) 212
prednisolone - therapeutic use (210) 210
severity of illness index (210) 210
follow-up studies (208) 208
azathioprine - therapeutic use (207) 207
dose-response relationship, drug (207) 207
research article (200) 200
patients (197) 197
sulfasalazine - metabolism (196) 196
general & internal medicine (195) 195
mice (193) 193
anti-inflammatory agents, non-steroidal - adverse effects (191) 191
medicine, general & internal (191) 191
digestive system (190) 190
prednisone - therapeutic use (190) 190
medicine & public health (185) 185
diseases of the osteoarticular system (184) 184
pregnancy (180) 180
administration, oral (179) 179
drug toxicity and drugs side effects treatment (172) 172
inflammatory bowel diseases - drug therapy (171) 171
recurrence (171) 171
gastroenterology. liver. pancreas. abdomen (167) 167
inflammation (166) 166
colitis, ulcerative - complications (164) 164
hydroxychloroquine - therapeutic use (164) 164
sulphasalazine (164) 164
crohn's disease (163) 163
infliximab (162) 162
spondylitis, ankylosing - drug therapy (162) 162
inflammatory joint diseases (160) 160
antirheumatic agents - administration & dosage (156) 156
colitis (156) 156
other diseases. semiology (153) 153
mesalamine - therapeutic use (148) 148
retrospective studies (148) 148
radiography (146) 146
stomach. duodenum. small intestine. colon. rectum. anus (145) 145
glucocorticoids - therapeutic use (142) 142
etanercept (141) 141
prospective studies (139) 139
colitis, ulcerative - therapy (136) 136
rheumatoid factor (135) 135
hydroxychloroquine (133) 133
colitis - drug therapy (131) 131
prognosis (131) 131
dermatology (130) 130
diagnosis, differential (130) 130
methotrexate - administration & dosage (130) 130
anti-inflammatory agents, non-steroidal - administration & dosage (127) 127
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4860) 4860
German (237) 237
French (160) 160
Japanese (127) 127
Russian (55) 55
Spanish (47) 47
Italian (45) 45
Chinese (32) 32
Dutch (29) 29
Danish (27) 27
Hungarian (19) 19
Korean (19) 19
Polish (19) 19
Portuguese (18) 18
Czech (12) 12
Finnish (10) 10
Norwegian (9) 9
Swedish (9) 9
Hebrew (8) 8
Romanian (6) 6
Turkish (4) 4
Bulgarian (3) 3
Croatian (3) 3
Lithuanian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text L’œil : miroir de la spondylarthrite systémique ?
by Rahmouni, S and Dhahri, R and Metoui, L and Slouma, M and Boussetta, N and Laajili, F and Louzir, B and Gharsallah, I and Othmani, S
La revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, pp. A204 - A204
Sulfasalazine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis
by Xu, Jinke and Tam, Mifong and Samaei, Sepideh and Lerouge, Sophie and Barralet, Jake and Stevenson, Mary M and Cerruti, Marta
Acta biomaterialia, ISSN 1742-7061, 01/2017, Volume 48, pp. 247 - 257
Catechols | Rectal drug delivery | Chitosan | Mucoadhesion | Ulcerative colitis | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Sulfasalazine - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Colon - pathology | Colon - drug effects | Body Weight - drug effects | Catechols - chemistry | Sulfasalazine - pharmacology | Colitis, Ulcerative - pathology | Mucins - chemistry | Sulfasalazine - metabolism | Colitis, Ulcerative - blood | Adhesives - chemistry | Drug Delivery Systems | Dose-Response Relationship, Drug | Animals | Chitosan - chemistry | Rectum - drug effects | Sulfasalazine - blood | Mice | Occult Blood | Colitis, Ulcerative - drug therapy | Hydrogels - chemistry | Drugs | Drug delivery systems | Drug therapy | Vehicles | Hypertension | Evaluation | Colon cancer | Aminosalicylic acids | Microbiota (Symbiotic organisms) | Analysis | Gastrointestinal system | Inflammatory bowel diseases | Hydrogels | Mucosa | Drug delivery | Sulfapyridine | Retention time | Tissues | Retention | Small intestine | Genipin | Degradation | Absorption | Rodents | Sulfasalazine | Colon | Intestinal microflora | Formulations | Effectiveness | Degradation products | Vessels | Oral administration | Byproducts | Crosslinking | Gastrointestinal tract | Catechol | Inflammatory bowel disease | Side effects | Flora | Rectum | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Photodegradation of sulfasalazine over Cu.sub.2O-BiVO.sub.4-WO.sub.3 nano-composite: Characterization and experimental design
by Omrani, Narges and Nezamzadeh-Ejhieh, Alireza
International journal of hydrogen energy, ISSN 0360-3199, 07/2020, Volume 45, Issue 38, p. 19144
Analysis | Sulfasalazine | Catalysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text BiVO.sub.4/WO.sub.3 nano-composite: characterization and designing the experiments in photodegradation of sulfasalazine
by Omrani, Narges and Nezamzadeh-Ejhieh, Alireza
Environmental science and pollution research international, ISSN 0944-1344, 12/2020, Volume 27, Issue 35, p. 44292
Semiconductors | Analysis | Sulfasalazine | Catalysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
by O'Dell, James R and Mikuls, Ted R and Taylor, Thomas H and Ahluwalia, Vandana and Brophy, Mary and Warren, Stuart R and Lew, Robert A and Cannella, Amy C and Kunkel, Gary and Phibbs, Ciaran S and Anis, Aslam H and Leatherman, Sarah and Keystone, Edward and CSP 551 RACAT Investigators
The New England journal of medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 4, pp. 307 - 318
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Inflammatory joint diseases | Biological and medical sciences | General aspects | Medical sciences | Diseases of the osteoarticular system | Hydroxychloroquine - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Double-Blind Method | Humans | Middle Aged | Immunoglobulin G - therapeutic use | Male | Hydroxychloroquine - adverse effects | Methotrexate - therapeutic use | Immunoglobulin G - adverse effects | Receptors, Tumor Necrosis Factor - therapeutic use | Methotrexate - adverse effects | Etanercept | Arthritis, Rheumatoid - drug therapy | Treatment Failure | Antirheumatic Agents - adverse effects | Female | Aged | Drug Therapy, Combination | Sulfasalazine - adverse effects | Antirheumatic Agents - therapeutic use | Care and treatment | Antirheumatic agents | Research | Comparative analysis | Rheumatoid arthritis | Hydroxychloroquine | Pain | Clinical trials | TNF inhibitors | Sulfasalazine | Methotrexate | Drug therapy | Patients | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Enzyme‐Responsive Controlled Release of Covalently Bound Prodrug from Functional Mesoporous Silica Nanospheres
by Popat, Amirali and Ross, Benjamin P and Liu, Jian and Jambhrunkar, Siddharth and Kleitz, Freddy and Qiao, Shi Zhang
Angewandte Chemie (International ed.), ISSN 1433-7851, 12/2012, Volume 51, Issue 50, pp. 12486 - 12489
colon targeting | sulfasalazine | nanoparticles | drug delivery | azo‐reductase | azo-reductase | Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Sulfapyridine - metabolism | Oxidoreductases - metabolism | Nanospheres - chemistry | Silicon Dioxide - chemistry | Sulfapyridine - chemistry | Prodrugs - chemistry | Sulfasalazine - metabolism | Drug Carriers - chemistry | Prodrugs - metabolism | Mesalamine - chemistry | Sulfasalazine - chemistry | Porosity | Mesalamine - metabolism | Hydrogen-Ion Concentration | Drugs | Sulfasalazine | Drug delivery systems | Silica | Vehicles | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Glutamate release by primary brain tumors induces epileptic activity
by Buckingham, Susan C and Campbell, Susan L and Haas, Brian R and Montana, Vedrana and Robel, Stefanie and Ogunrinu, Toyin and Sontheimer, Harald
Nature medicine, ISSN 1078-8956, 10/2011, Volume 17, Issue 10, pp. 1269 - 1274
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Sulfasalazine - therapeutic use | Humans | Electrophysiology | Cell Transplantation | Sulfasalazine - pharmacology | Electroencephalography | Brain Neoplasms - complications | Brain Neoplasms - drug therapy | Mice, SCID | Epilepsy - etiology | Brain Neoplasms - metabolism | Glioma - metabolism | Amino Acid Transport System y+ - metabolism | Animals | Analysis of Variance | Amino Acid Transport System y+ - antagonists & inhibitors | Glutamic Acid - metabolism | Mice | Epilepsy - pathology | Glioma - drug therapy | Complications and side effects | Prognosis | Epilepsy | Brain tumors | Physiological aspects | Development and progression | Genetic aspects | Research | Glutamate | Risk factors | Brain | Convulsions & seizures | Biomedical research | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice
by Kankala, Ranjith Kumar and Kuthati, Yaswanth and Sie, Huei-Wun and Shih, Hung-Yuan and Lue, Sheng-I and Kankala, Shravankumar and Jeng, Chien-Chung and Deng, Jin-Pei and Weng, Ching-Feng and Liu, Chen-Lun and Lee, Chia-Hung
Journal of colloid and interface science, ISSN 0021-9797, 11/2015, Volume 458, pp. 217 - 228
Nanoparticles | Eudragit copolymer | Inflammatory | Sulfasalazine | Oral drug delivery | Layered double hydroxides | Physical Sciences | Chemistry | Chemistry, Physical | Science & Technology | Sulfasalazine - therapeutic use | Hydroxides - chemistry | Nanoparticles - chemistry | Humans | Biological Availability | Sulfasalazine - pharmacology | Edema - drug therapy | Polymethacrylic Acids - chemistry | Spectroscopy, Fourier Transform Infrared | Drug Carriers - chemistry | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | HT29 Cells | Animals | Sulfasalazine - pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Inflammation - drug therapy | Cell Line, Tumor | Mice | Laminated metals | Hydroxides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
by Wang, Yongjun and Parker, Claire E and Bhanji, Tania and Feagan, Brian G and MacDonald, John K and MacDonald, John K
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2016, Volume 2016, Issue 6, pp. CD000543 - CD000543
Colitis, Ulcerative | Mesalamine | Administration, Oral | Gastroenterology & hepatology | Anti‐Inflammatory Agents, Non‐Steroidal | Induction Chemotherapy | Ulcerative colitis: induction of remission | Randomized Controlled Trials as Topic | Inflammatory bowel disease | 5‐ASA therapy, topical and oral | Treatment Failure | Child health | Gastroenterology | Sulfasalazine | Medicine General & Introductory Medical Sciences | ULCERATIVE COLITIS ‐ INDUCTION OF REMISSION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sulfasalazine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Mesalamine - adverse effects | Humans | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Induction Chemotherapy - methods | Colitis, Ulcerative - drug therapy | Sulfasalazine - adverse effects | Mesalamine - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights